After transitioning into board roles from my execitive roles, I joined a number of NED platforms and met some incredibly interesting people.
Some, seasoned board members who shared their wisdom, others thinking of joining a board.
One such person asked me for my thoughts on my first board role.
This rambling led to me creating a 7 part series of posts which I wish I had seen before my first role.
Diagnostics start-ups live in the space between science and business.
On one side: the promise of faster, more accurate testing that can change patient care.
On the other: regulatory complexity, market competition, and the constant pressure to raise capital without losing focus.
As a Non-Executive Director in this sector, I’ve seen how success is rarely about just the product.
It’s about:
Asking the right questions early.
Making finance part of every conversation.
Building resilience into operations before you need it.
Over the next seven posts, I’ll share boardroom insights from my first-hand experience in diagnostics, covering topics from governance and funding to culture and risk.
This isn’t a technical series.
It’s a practical, human one for founders, executives, investors, and anyone curious about how diagnostics companies move from lab bench to market launch.